Chinese outbound investment deal value in pharmaceuticals 2016-2019, by type
Business activities in the health and pharmaceutical industry slumped in China in 2019 after a robust performance in the previous few years. The value of outbound investment deals conducted by financial buyers in the pharmaceutical sector from mainland China amounted to around 536 million U.S. dollars in 2019, falling from around 3.2 billion in the previous year.